蒽环类药物联合阿糖胞苷治疗急性非淋巴细胞白血病 (急非淋 ,ANLL )可使将近 70 %的患者获得完全缓解 ,但仍有 30 %左右的患者未能达到缓解 ,这部分病例的治疗成为提高急非淋疗效的关键。大剂量阿糖胞苷对部分耐药病例有效 ,但其毒副作用较大 ,应用受到限制。高三尖杉酯碱与蒽 Anthracyclines combined with cytarabine for acute non-lymphocytic leukemia (an acute non-lymphocytic leukemia, ANLL) can achieve complete remission in nearly 70% of patients, but still about 30% of patients fail to achieve remission, in some cases Treatment has become the key to improving the efficacy of acute non-lymphocin. High-dose cytarabine is effective in some cases of drug resistance, but its toxic side effects are large and its application is limited. Homoharringtonine and Thallium